placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
Some sites say to eat starchy foods along with protein, while others say to avoid protein Almost all say to avoid eating a lot of fat if you have recurrent or chronic pancreatitis
Evidence Level [EL] 1)
People who live with obesity face Semaglutide and phentermine are both popular weight loss drugs, but they are very different
After 10-15 years on the job, most first responders deal with: Chronic tendon injuries (rotator cuff, Achilles, knee) Lower back pain from gear and lifting Muscle tears that never fully heal Joint pain that makes every shift harder Exhaustion that sleep doesnt fix Slow recovery between shifts Your doctor probably told you to take ibuprofen and rest. But you cant restyouve got a shift tomorrow